Literature DB >> 20026421

The complexity of the complicity of mast cells in cancer.

Hovav Nechushtan1.   

Abstract

Mast cells are evolutionarly ancient cells of the immune cells which can secrete a variety of effector molecules. Animal and pathologic studies suggest that mast cells may promote tumor growth in some cancer types but may act in an opposite manner in others. In several mouse models a critical role of mast cells for tumor promotion was demonstrated. In humans mast cells are dependent upon the tyrosine kinase receptor c-Kit. This receptor is inhibited by many of the new anti-cancer tyrosine kinase inhibitors including Pazopanib, Imatinib and Masitinib. These drugs probably ablate some tumor mast cells, in addition to their other known antitumor effects. Understanding the complex roles of mast cells in cancer should aid in understanding mechanisms of current tyrosine kinase inhibitors, and the development of innovative anti-cancer therapies. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20026421     DOI: 10.1016/j.biocel.2009.12.015

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  11 in total

1.  HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1.

Authors:  David E Cochrane; Robert E Carraway; Kimberly Harrington; Melissa Laudano; Stephen Rawlings; Ross S Feldberg
Journal:  Inflamm Res       Date:  2011-09-17       Impact factor: 4.575

Review 2.  Carcinogenesis: the cancer cell-mast cell connection.

Authors:  Maria-Angeles Aller; Ana Arias; Jose-Ignacio Arias; Jaime Arias
Journal:  Inflamm Res       Date:  2018-11-20       Impact factor: 4.575

3.  Prognostic value of tumor-infiltrating mast cells in outcome of patients with esophagus squamous cell carcinoma.

Authors:  Ashraf Fakhrjou; Seid Mahdi Niroumand-Oscoei; Mohamad Hosein Somi; Morteza Ghojazadeh; Shahnaz Naghashi; Shabnam Samankan
Journal:  J Gastrointest Cancer       Date:  2014-03

4.  Mast Cells in Adjacent Normal Colon Mucosa rather than Those in Invasive Margin are Related to Progression of Colon Cancer.

Authors:  Qing Xia; Ya Ding; Xiao-Jun Wu; Rui-Qing Peng; Qiang Zhou; Jing Zeng; Jing-Hui Hou; Xing Zhang; Yi-Xin Zeng; Xiao-Shi Zhang; Ying-Bo Chen
Journal:  Chin J Cancer Res       Date:  2011-12       Impact factor: 5.087

5.  No relationship between the distribution of mast cells and the survival of stage IIIB colon cancer patients.

Authors:  Qing Xia; Xiao-Jun Wu; Qiang Zhou; Jing-Hui Hou; Zhi-Zhong Pan; Xiao-Shi Zhang
Journal:  J Transl Med       Date:  2011-06-09       Impact factor: 5.531

Review 6.  IgE-based immunotherapy of cancer: challenges and chances.

Authors:  J Singer; E Jensen-Jarolim
Journal:  Allergy       Date:  2013-10-14       Impact factor: 13.146

7.  Increased mast cell counts in benign and malignant salivary gland tumors.

Authors:  Zohreh Jaafari-Ashkavandi; Mohammad-Javad Ashraf
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2014-03-05

8.  CKMT1B is a potential prognostic biomarker and associated with immune infiltration in Lower-grade glioma.

Authors:  Huadi Shi; Yuling Song; Zhi Song; Chun Huang
Journal:  PLoS One       Date:  2021-01-19       Impact factor: 3.240

Review 9.  Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.

Authors:  Marlies E Heuvers; Joachim G Aerts; Robin Cornelissen; Harry Groen; Henk C Hoogsteden; Joost P Hegmans
Journal:  BMC Cancer       Date:  2012-12-05       Impact factor: 4.430

Review 10.  Mast cells as a potential prognostic marker in prostate cancer.

Authors:  Gianluigi Taverna; Guido Giusti; Mauro Seveso; Rodolfo Hurle; Piergiuseppe Colombo; Sanja Stifter; Fabio Grizzi
Journal:  Dis Markers       Date:  2013-11-11       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.